Trials / Completed
CompletedNCT00215592
Open Label, Zonegran (Zonisamide) In Partial Onset Seizures
An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of adjunctive open label Zonegran treatment in patients with refractory partial seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zonegran |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2007-07-01
- First posted
- 2005-09-22
- Last updated
- 2016-01-08
Locations
33 sites across 7 countries: Austria, Denmark, France, Germany, Italy, Norway, United Kingdom
Source: ClinicalTrials.gov record NCT00215592. Inclusion in this directory is not an endorsement.